Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 147
Immune Disorders Drugs 79
Genomics 78
Biopharmaceuticals 77
Drug Discovery 66
Oncology Drugs 51
Biotechnology 49
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 41
Hematological Drugs 39
Biosimilars and Biosuperiors 30
Alzheimer's Disease Drugs 27
Cardiovascular Drugs 26
Clinical Trials 26
Allergy and Immunology 20
Infusions and Injectables 20
Optical Disorders Drugs 19
Infectious Diseases Drugs 18
Respiratory Drugs 18
Mental Disorders Drugs 18
Gastrointestinal Drugs 17
Needles and Syringes 16
E-Healthcare 14
Psoriasis Drugs 14
Pharmaceutical Manufacturing 14
Immunosuppressive Drugs 14
Neurology 13
Healthcare Services 13
Drug Delivery 12
Hematology 12
Endocrine and Metabolic Disorders Drugs 12
Lymphoma Drugs 11
Analgesics 10
Leukemia Drugs 9
Optical 9
Diagnostics 9
Liver and Kidney Disorders Drugs 9
Therapeutic Area 7
Drugs by Therapeutic Area 7
Pulmonary Medicine 7
Company Reports 6
Enzymes 6
Medical Devices 6
Hospital Management 5
Cardiology 5
Oncology 5
Schizophrenia Drugs 5
Proteomics 4
Neurology Devices 4
Vaccines 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Pharmacoeconomics 3
Lung Cancer Drugs 3
Stem Cells 3
Biomaterials 3
Dermatology 3
Mental Health 3
Vitamins and Dietary Supplements 3
Laboratory Equipment 3
Gastroenterology 3
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Skin Cancer Drugs 2
Nanomedicine 2
Anxiety Drugs 2
Asthma Drugs 2
Urology and Nephrology 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Prostate Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Medical Imaging 1
Orthopedic Devices 1
Infectious Disease Testing 1
Computed Tomography 1
Transdermal and Transmucosal Drug Delivery 1
Biomarkers 1
Surgical Procedures 1
Contrast Media 1
Kidney Cancer Drugs 1
Antibiotics 1
Clinical Skills 1
Pediatrics 1
Anatomy 1
Allergy Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



272 reviews

908 Results (Page 18 of 46)
- Relevance
  Sort by

Hodgkin Lymphoma Treatment Market by Type, Treatment, End-User - Global Forecast 2025-2030

 Report
October 2024
199 Pages
Global

From

€3267EUR$3,545USD£2,762GBP

€3630EUR$3,939USD£3,069GBP

Non-Hodgkin Lymphoma Treatment Market by Treatment Type, Application, End-User - Global Forecast 2025-2030

 Report
October 2024
183 Pages
Global

From

€3267EUR$3,545USD£2,762GBP

€3630EUR$3,939USD£3,069GBP

Leukemia Therapeutics Market by Type, Treatment Type, Molecule Type, Mode of Administration, Gender - Global Forecast 2025-2030

 Report
October 2024
186 Pages
Global

From

€3267EUR$3,545USD£2,762GBP

€3630EUR$3,939USD£3,069GBP

Colorectal Cancer Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4138EUR$4,490USD£3,499GBP

Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

 Report
October 2021
288 Pages
Global

From

€3318EUR$3,600USD£2,805GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

US Biosimilar industry outlook to 2028

 Report
October 2023
85 Pages
United States

From

€4470EUR$4,850USD£3,779GBP

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

 Report
August 2018
340 Pages
Global

From

€3225EUR$3,499USD£2,726GBP

T-cell Lymphoma Market 2024-2028

 Report
August 2024
135 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€4147EUR$4,500USD£3,506GBP

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

 Report
July 2024
190 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region

 Report
March 2024
200 Pages
Global

From

€3825EUR$4,150USD£3,234GBP

Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
230 Pages
Global

From

€1843EUR$2,000USD£1,558GBP

Biologics Market Report 2025-2035

 Report
March 2025
367 Pages
Global

From

€5325EUR$5,980USD£4,350GBP

Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size and Key Geographical Regions

 Report
November 2024
799 Pages
Global

From

€4423EUR$4,799USD£3,739GBP

Diagnostic Imaging Collaboration and Licensing Deals 2016-2024

 Report
November 2024
350 Pages
Global

From

€3682EUR$3,995USD£3,113GBP

Needle-Free Injector Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2022
100 Pages
Global

From

€3500EUR$4,068USD£3,063GBP

Nasal Drug Delivery Technology Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4138EUR$4,490USD£3,499GBP

Asthma Therapeutics Market Report by Drug Class, Product Type, Treatment Type, Route of Administration, and Region 2024-2032

 Report
August 2024
141 Pages
Global

From

€2764EUR$2,999USD£2,337GBP

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

 Report
January 2019
230 Pages
Global

From

€3685EUR$3,999USD£3,116GBP

Antidepressants Drugs Market by Drug Class, Indication, Route of Administration, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
187 Pages
Global

From

€3267EUR$3,545USD£2,762GBP

€3630EUR$3,939USD£3,069GBP

908 Results (Page 18 of 46)
- 1
- 16
- 17
- 18
- 19
- 20

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.